Related Experiment Videos

CD30-positive anaplastic variant diffuse large B cell lymphoma: a rare case presented with cutaneous involvement

Insights

A rare case of CD30-positive diffuse large B cell lymphoma, anaplastic variant, presented with both lymph node and skin lesions. The patient achieved complete remission with chemotherapy.

Area of Science:

  • Hematology
  • Oncology
  • Dermatology

Background:

  • Diffuse large B cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
  • The anaplastic variant of DLBCL is rare and characterized by specific morphological features.
  • CD30 expression can be observed in certain subtypes of DLBCL.

Observation:

  • A 67-year-old male presented with cervical lymphadenopathy and tenderness.
  • Biopsy revealed pleomorphic large cells positive for CD30, but negative for B and T cell markers.
  • Subsequent skin ulceration showed similar atypical cells in the dermis and epidermis.

Findings:

  • Immunohistochemistry confirmed CD30, CD45, and PAX5 positivity in lesional cells.
  • Absence of CD3, CD10, CD20, CD15, Bcl-2, EBER ISH, EMA, and ALK supported the diagnosis.
  • The patient was diagnosed with CD30-positive DLBCL, anaplastic variant, with nodal and cutaneous involvement.

Implications:

  • This case highlights a rare presentation of DLBCL, anaplastic variant, with unusual skin involvement.
  • The findings underscore the importance of thorough diagnostic workup for atypical lymphoid proliferations.
  • Successful treatment with CHOP chemotherapy suggests this regimen may be effective for this rare subtype.